On this week's episode of the Business of Biotech, Matt Winton, Ph.D., Chief Commercial and Business Officer at CervoMed, talks about preparing for the late-stage development of neflamapimod in ...
Federal investment in basic science built America’s innovation engine, but declining support is threatening U.S. leadership, ...
A recent Executive Order (EO) de-risks psychedelic drug development by clarifying regulations, but scalable treatment models ...
Healthcare systems must turn proven research into patient care faster with practical infrastructure, product champions, trust ...
As fans of classic Japanese movies may remember, the pharmaceutical industry has experience with Godzilla. In the 1962 movie King Kong vs Godzilla, Mr Tako, director of Pacific Pharmaceuticals, helps ...
This week's episode of the Business of Biotech was recorded at the BIO Convention in San Diego, where guest Maha Radhakrishnan, M.D., Executive Partner, Private Equity, at Sofinnova, spoke about her ...
Bouncing around the San Diego Convention Center’s 2.6 million square feet for four days is its own kind of flustery exercise, but in the age of Zoom it’s a more-than-welcome excursion. It’s hard to ...
Canada has unique medical information requirements that demand professionalism, compassion, and local expertise. In this video, Larry Hough, Senior Director of Pharmacovigilance and Medical ...
On this week's episode of the Business of Biotech, Al Sandrock, M.D., Ph.D., President and CEO at Voyager Therapeutics, talks about why tau is becoming a central target in Alzheimer’s drug development ...
The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion's (OPDP’s) 2026 untitled letters do more than identify a handful of promotional missteps. Read together with the agency’s ...
On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gamma delta T cells may have an edge against cancer, including solid tumors like glioblastoma.
The North Carolina Biotechnology Center leads life sciences economic development for North Carolina by supporting the progression of ideas from research lab to the marketplace. NCBiotech invests in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results